HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-[5-(4-Methanesulfonylphenyl)-2,3-dihydrobenzofuran-2-yl]piperidine-1-carbonitrile → 1-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4-[5-(4-methanesulfonyl-phenyl)-2,3-dihydro-benzofuran-2-yl]-piperidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-[5-(4-Methanesulfonylphenyl)-2,3-dihydrobenzofuran-2-yl]piperidine-1-carbonitrile | HCID 86675672 | — |
| Reactant | HCID 178513214 | HCID 178513214 | — |
| Product | 1-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4-[5-(4-methanesulfonyl-phenyl)-2,3-dihydro-benzofuran-2-yl]-piperidine | HCID 71208414 | — |
Reaction Steps
The title compound is prepared from 4-[5-(4-methanesulfonyl-phenyl)-2,3-dihydro-benzofuran-2-yl]-piperidine-1-carbonitrile and N-hydroxy-cyclopropanecarboxamidine following a procedure analogous to that described in Example 2. LC (method 2): tR=1.08 min; Mass spectrum (ESI+): m/z=466 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08778926B2 |
| Source dataset | uspto-grants-2014_07 |
| ORD ID | ord-ae47ff2612004ad595ca79c16b1b87df |
| Source note | uspto-grants-2014_07 |